Craneware
CRW · AIM · Health Care · mcap £356m · 1100.0p
Craneware sells cloud software and data analytics, under the Trisus platform, that help US hospitals manage pricing, billing, drug-discount compliance and costs. Revenue is mostly recurring subscriptions.
| Date | Type | Announcement | Day |
|---|---|---|---|
| 22 Sep 26 | Purchase of Shares by Director
Non-Executive Director Susan Nelson purchased 1,408 ordinary shares at 1,054 pence per share. |
+3.8% | |
| 21 Sep 26 | Results | FY26 Final Results
FY26 revenue flat at $206m and adjusted EBITDA up 3% to $67.1m, but profit guidance cut for FY27 following cyber incident. |
−25.8% |
|
below expectations Revenue $206.0m ($205.7m)Adjusted EBITDA $67.1m ($65.3m)ARR $185m ($184m)Net Revenue Retention 100% (107%)Statutory Profit before tax $25.8m ($24.0m)Operating Cash Conversion 98% (94%)
|
|||
| 20 Jul 26 | Notice of Cyber Security Incident
Craneware identified unauthorised access to subset of data environment; incident contained with no operational disruption. |
−6.3% | |
|
Data exfiltrated Significant volume of file names
|
|||
| 06 Jul 26 | Purchase of Shares by Director
Keith Neilson's pension scheme purchased 9,074 shares at 1,102 pence per share. |
+3.0% | |
| 03 Jul 26 | Purchase of Shares by Director
Chair Will Whitehorn purchased 640 ordinary shares at 1,173 pence per share. |
−26.0% | |
| 03 Jul 26 | Trading update | FY26 Trading Update
FY26 revenue and EBITDA expected below market at US$205-208m and US$65-67m respectively due to 340B timing. |
−26.0% |
|
below expectations FY26 Revenue guidance US$205-208 million (FY25 broadly in line)FY26 Adjusted EBITDA guidance US$65-67 million (FY25 broadly in line)Outstanding 340B qualifying drug purchases US$500 million
|
|||
| 05 May 26 | Grant of Share Options to Directors
Three directors granted share options under the SAYE scheme at £11.594 per share. |
+1.2% | |
| 15 Apr 26 | Block Admission
Block admission statement for employee share schemes covering six months to 15 April 2026; no shares issued. |
+1.7% | |
| 13 Apr 26 | Director dealing | Grant of Share Option to PDMR
Chief Legal Officer Eric Carter granted share option to acquire 1,004 ordinary shares under Employee Stock Purchase Plan. |
+0.4% |
| 20 Mar 26 | Dividend Currency Election
Craneware sets exchange rate of $1.33 for shareholders electing to receive interim dividend in US dollars. |
−0.7% | |
| 16 Mar 26 | Share buyback programme and Total Voting Rights
Craneware launches $25 million share buyback programme to enhance shareholder returns and offset employee share scheme dilution. |
+4.3% | |
|
Share buyback programme $25 millionMaximum ordinary shares to be purchased 3,542,956Issued share capital 35,542,169 Ordinary SharesOrdinary Shares with voting rights 35,514,105
|
|||
| 02 Mar 26 | Results | FY26 Interim Results
H1 FY26 revenue up 6% to $105.7m, adjusted EBITDA up 10% to $33.4m, with double-digit EPS growth and $25m buyback announced. |
+1.0% |
|
in line with market expectations expectations Revenue $105.7m ($100.0m)Adjusted EBITDA $33.4m ($30.3m)Adjusted Basic EPS 58.7 cents (50.6 cents)Annual Recurring Revenue $184.2m ($177.3m)Total cash and cash equivalents $71.2m ($72.2m)Total bank debt $23.4m ($31.6m)
|
|||
| 20 Jan 26 | H1 FY26 Trading Update and Notice of Results
H1 FY26 revenue grew 6% to $106m, Adjusted EBITDA up double-digit to $33.4m, debt reduced to $23.4m. |
−2.7% | |
|
in line with current market expectations expectations Revenue c.$106m ($100m)Adjusted EBITDA c.$33.4m ($30.3m)Annual Recurring Revenue (ARR) c.$184.3m ($177.3m)Total bank debt $23.4m ($31.6m)Total cash reserves $71.2m ($72.2m)
|
|||
| 28 Nov 25 | Dividend Currency Election
Craneware sets dividend exchange rate at $1.32 per pound for shareholders electing US dollar payment. |
−0.5% | |
| 21 Nov 25 | AGM Statement and Board Changes
Senior Non-Executive Director David Kemp retires; three board members assume new roles. |
+2.4% | |
|
in line expectations |
|||
| 13 Nov 25 | Reduction of Capital effective
Reduction of Capital effective following Court of Session confirmation and Registrar registration. |
−1.0% | |
|
Additional distributable reserves created US$ 284,185,184.18
|
|||
| 06 Nov 25 | Reduction of Capital confirmed
Court confirms reduction of capital creating US$284.2m in distributable reserves. |
−4.5% | |
|
Additional distributable reserves created US$284,185,184.18
|
|||
| 22 Oct 25 | Results | Annual Report, Notice of AGM, Directorate Change
Senior Non-Executive Director David Kemp retiring from board after nearly six years of service. |
−0.4% |
| 17 Sep 25 | Grant of Long Term Incentive Plan Awards
LTIP awards granted to three Directors and Chief Legal Officer, vesting over five years subject to performance conditions. |
+4.0% | |
| 15 Sep 25 | Results | FY25 Final Results
Revenue grew 9% to $205.7m, adjusted EBITDA up 12% to $65.3m with improved margins and cash position. |
+2.6% |
|
Revenue $205.7m ($189.3m)Adjusted EBITDA $65.3m ($58.3m)Annual Recurring Revenue $184.0m ($172.0m)Net Revenue Retention 107% (98%)Total Cash $55.9m ($34.6m)Total Bank Debt $27.7m ($35.4m)
|
|||
| 01 Sep 25 | Bank Refinancing
Craneware refinances $100m revolving credit facility on improved terms with four-bank consortium for three years. |
+0.5% | |
|
ahead of prior expectations expectations New unsecured RCF $100mAccordion facility $100mProposed additional distributable reserves $284.2mBank debt at 30 June 2025 $27.7m ($35.4m (FY24))Cash reserves at 30 June 2025 $55.9m ($34.6m (FY24))
|
|||
| 01 Aug 25 | Proposed Reduction of Capital
Craneware proposes reduction of capital to create US$284.2m in distributable reserves for future shareholder returns. |
+1.8% | |
|
Additional distributable reserves to be created US$284,185,184.18
|
|||
| 16 Jul 25 | Trading update | FY25 Trading Update
FY25 revenue grew 9% to $205.7m with adjusted EBITDA up 12% to over $65m, ahead of expectations. |
+10.2% |
|
ahead expectations Adjusted EBITDA over $65m ($58.3m)Revenue $205.7m ($189.3m)Annual Recurring Revenue c.$184m ($172.0m)Net Revenue Retention 107% (98%)Total bank debt $27.7m ($35.4m)Total cash reserves $55.9m ($34.6m)
|
|||
| 11 Jun 25 | Response to Rule 2.8 Announcement by Bain Capital
Board rejects Bain Capital takeover proposal at £26.50 per share, citing undervaluation and strong trading performance. |
−0.7% | |
|
Rejected offer price per share £26.50
|
|||
| 11 Jun 25 | Rule 2.8 Announcement
Bain Capital confirms no intention to make firm offer for Craneware following Rule 2.8 announcement. |
−0.7% | |
| 16 May 25 | Response to Statement by Bain Capital
Bain Capital assessing possible offer; board confirms no proposal received; deadline 13 June 2025. |
+7.8% | |
| 16 May 25 | Offer | Statement re Possible Offer
Bain Capital confirms it is assessing a possible offer to acquire Craneware but has not approached the board. |
+7.8% |
| 28 Apr 25 | Purchase of Shares by Director and TVR
Chair Will Whitehorn purchased 1,911 ordinary shares at 1,584 pence per share on 24 April 2025. |
+4.2% | |
| 21 Mar 25 | Dividend Currency Election
Craneware confirms USD/GBP exchange rate of 1.30 for shareholders electing dollar dividend payments. |
−0.5% | |
| 11 Mar 25 | Results | FY25 Interim Results
H1 FY25 revenue grew 10% to $100.0m with adjusted EBITDA up 10% to $30.3m, returning to double-digit growth. |
+0.6% |
|
in line with current market expectations expectations Group revenue $100.0m ($91.2m)Adjusted EBITDA $30.3m ($27.5m)Adjusted Basic EPS 50.6 cents (42.8 cents)Annual Recurring Revenue $177.3m ($171.4m)Total cash and cash equivalents $72.2m ($63.9m)Total bank debt $31.6m ($59.2m)
|
|||
| 13 Jan 25 | Trading update | H1 FY25 Trading Update
H1 FY25 revenue $100.0m (+10%), adjusted EBITDA $30.3m, ARR $177m (+3%), debt reduced to $31.6m. |
+2.7% |
|
in line expectations Revenue $100.0m ($91.2m)Adjusted EBITDA $30.3m ($27.5m)Annual Recurring Revenue (ARR) $177m ($171.4m)Total bank debt $31.6m ($59.2m)Total cash reserves $72.2m ($63.9m)
|
|||
| 29 Nov 24 | Dividend Currency Election
Craneware confirms exchange rate of $1.26 for US dollar dividend payments to elected shareholders. |
+2.1% | |
| 13 Nov 24 | AGM Statement and Board Changes
Senior Non-Executive Director and Non-Executive Director step down; US healthcare executive Tamra Minnier joins board. |
+0.9% | |
| 18 Sep 24 | Exercise of Share Options
Three executive directors exercised share options on 16 September 2024. |
−3.1% | |
| 17 Sep 24 | Grant of Long Term Incentive Plan Awards
LTIP awards granted to CEO, CFO, Chief People Officer and Chief Legal Officer, vesting over five years subject to performance. |
+2.7% | |
| 10 Sep 24 | Release and discharge of security in the Company
Craneware released all security over its assets following satisfaction of Sentry acquisition loan performance conditions. |
−2.1% | |
| 03 Sep 24 | Results | FY24 Final Results
FY24 revenue rose 9% to $189.3m, adjusted EBITDA up 6% to $58.3m, beating expectations with bank debt cut sharply. |
+7.7% |
|
above expectations Revenue $189.3m ($174.0m)Adjusted EBITDA $58.3m ($54.9m)Annual Recurring Revenue $172.0m ($169.0m)Adjusted basic EPS 94.8 cents (87.0 cents)Total Bank Debt $35.4m ($83.0m)Proposed final dividend 16.0p per share (16.0p)
|
|||
| 18 Jul 24 | FY24 Trading Update and Notice of Results
FY24 revenue expected to exceed $188m, adjusted EBITDA at least $58m, with debt reduced to $35.4m. |
+1.7% | |
|
above upper end of market expectations expectations Revenue >$188m ($174.0m)Adjusted EBITDA $58m ($54.9m)Total bank debt $35.4m ($83m)Annual Recurring Revenue $172m ($169m)Cash reserves $34.6m ($78.5m)Dividends returned $12.8m ($12.1m)
|
|||
| 02 Jul 24 | Craneware forms Alliance with Microsoft
Craneware signs strategic alliance with Microsoft to integrate Azure cloud and AI into Trisus healthcare platform offerings. |
+0.9% | |
| 16 Apr 24 | Extension of share buyback programme
Share buyback programme extended by three months to 17 July 2024 under existing terms. |
−0.9% | |
| 22 Mar 24 | Dividend Currency Election
Company sets exchange rate of $1.27 for shareholders electing to receive dividend in US dollars. |
+0.9% | |
| 04 Mar 24 | Results | Half-year Results
H1 revenues grew 8% to $91.2m and adjusted EBITDA rose 8% to $27.5m, with strong customer retention and improved market conditions. |
−1.4% |
|
in line with current consensus expectations Revenues $91.2m ($84.7m)Adjusted EBITDA $27.5m ($25.5m)Annual Recurring Revenue $171.4m ($166.4m)Adjusted Basic EPS 42.8 cents per share (41.0 cents per share)Cash reserves $63.9m ($90.8m)Total Bank Debt $59.2m ($107.9m)
|
|||
| 17 Jan 24 | Trading Update and Notice of Results
H1 FY24 revenue grew 8% to $91m and adjusted EBITDA up 8% to $27.5m, with ARR growth of 3% to $171.4m. |
+1.7% | |
|
in line with Board expectations expectations Revenue c.$91m ($84.7m)Adjusted EBITDA c.$27.5m ($25.5m)Annual Recurring Revenue (ARR) c.$171.4m ($166.4m)Net Revenue Retention 100%Total bank debt $59.2m ($107.9m)Total cash reserves $63.9m ($90.8m)
|
|||
| 24 Nov 23 | Dividend Currency Election
Craneware sets dividend currency election exchange rate at $1.25 per pound. |
+2.5% | |
| 16 Nov 23 | AGM Statement
Craneware reports continued positive financial and operational performance with growing partner opportunities and strengthening sales pipeline. |
+0.3% | |
|
in line expectations |
|||
| 01 Nov 23 | Director dealing | Exercise of SAYE Options, Director Dealing & TVR
CEO and CFO exercised SAYE options; CEO now holds 9.81% of voting rights. |
+2.2% |
| 17 Oct 23 | Extension of share buyback programme
Extended share buyback programme by three months to 17 January 2024 under existing terms. |
+1.0% | |
Company filings. Not investment advice.